- The Federal Government will share some of its surplus supply of AstraZeneca’s vaccine with Canada and Mexico.
- Moderna began testing a version of its COVID-19 vaccine that can be safely stored using normal refrigeration. Moderna also began testing its vaccine in infants and children.
- A new study found that Pfizer’s vaccine is 63% effective after one dose.
- The National Institutes of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci and other public health experts are trying to ease concerns about AstraZeneca’s COVID-19 vaccine after European regulators began reviewing reports of blood clots associated with the vaccine.
- The CDC has updated many of its guidances including Vaccination Considerations for People who are Pregnant or Breastfeeding; COVID-19 in Children and Teens; Selected Adverse Events Reported after COVID-19 Vaccination.
White House and Federal Agencies
- The Federal Government will share some of its surplus supply of AstraZeneca’s vaccine with Canada and Mexico.
Centers for Disease Control and Prevention (CDC) Updates
- A new study by the CDC found that many that were most severely impacted by COVID-19 are not receiving enough vaccine.
- The CDC is studying if three-feet of distance is as effective as the currently recommended six-feet of distance to protect against COVID-19 transmission. Shortening this distance recommendation could make it easier to reopen schools for in-person learning.
- The CDC updated its websites for:
- Cases in the U.S.
- Variant Proportions in the U.S.
- Racial and Ethnic Disparities in COVID-19 Incidence by Age, Sex, and Period Among Persons Aged <25 Years – 16 U.S. Jurisdictions, January 1-December 31, 2020
- COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons – United States, December 14, 2020−February 14, 2021
- Overall US COVID-19 Vaccine Distribution and Administration Update as of Thu, 18 Mar 2021 06:00:00 EST
- How to talk about COVID-19 vaccines with friends and family
- COVID-19 Vaccinations
- Holiday Tips
- Things to Know about the COVID-19 Pandemic
- Older Adults
- Vaccination Considerations for People who are Pregnant or Breastfeeding
- COVID-19 in Children and Teens
- What To Do if You Are Sick
- Frequently Asked Questions
- Selected Adverse Events Reported after COVID-19 Vaccination
Economy, Vaccines, Testing and Treatment
- President Biden says the U.S. will meet his goal of at least 100 million first doses of COVID-19 vaccines in his first 100 days in office by Friday.
- Former President Donald Trump encouraged everyone to get the COVID-19 vaccine.
- The Federal Government is distributing $12.25 billion to improve COVID-19 testing. $10 billion of that total is reserved for schools to help them reopen while $2.25 billion is going towards testing in underserved communities.
- Moderna began testing a version of its COVID-19 vaccine that can be safely stored using normal refrigeration.
- Moderna also began testing its vaccine in infants and children.
- A new study found that Pfizer’s vaccine is 63% effective after one dose.
- The Food and Drug Administration (FDA) created a new public dashboard that allows people to search for information about adverse events reported on the treatments and vaccines that received emergency use authorizations during the pandemic.
- The National Institutes of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci and other public health experts are trying to ease concerns about AstraZeneca’s COVID-19 vaccine after European regulators began reviewing reports of blood clots associated with the vaccine.
